"Antifungal Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
| Descriptor ID |
D000935
|
| MeSH Number(s) |
D27.505.954.122.136
|
| Concept/Terms |
Antifungal Agents- Antifungal Agents
- Agents, Antifungal
- Therapeutic Fungicides
- Fungicides, Therapeutic
|
Below are MeSH descriptors whose meaning is more general than "Antifungal Agents".
Below are MeSH descriptors whose meaning is more specific than "Antifungal Agents".
This graph shows the total number of publications written about "Antifungal Agents" by people in this website by year, and whether "Antifungal Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 0 | 3 |
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 3 | 5 |
| 1997 | 9 | 5 | 14 |
| 1998 | 2 | 0 | 2 |
| 1999 | 3 | 3 | 6 |
| 2000 | 4 | 5 | 9 |
| 2001 | 9 | 7 | 16 |
| 2002 | 6 | 8 | 14 |
| 2003 | 20 | 5 | 25 |
| 2004 | 12 | 9 | 21 |
| 2005 | 19 | 4 | 23 |
| 2006 | 25 | 8 | 33 |
| 2007 | 13 | 8 | 21 |
| 2008 | 15 | 7 | 22 |
| 2009 | 12 | 7 | 19 |
| 2010 | 15 | 6 | 21 |
| 2011 | 17 | 9 | 26 |
| 2012 | 17 | 16 | 33 |
| 2013 | 12 | 11 | 23 |
| 2014 | 16 | 14 | 30 |
| 2015 | 17 | 10 | 27 |
| 2016 | 18 | 8 | 26 |
| 2017 | 15 | 9 | 24 |
| 2018 | 15 | 11 | 26 |
| 2019 | 12 | 7 | 19 |
| 2020 | 6 | 5 | 11 |
| 2021 | 6 | 12 | 18 |
| 2022 | 3 | 13 | 16 |
| 2023 | 0 | 5 | 5 |
| 2024 | 5 | 6 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antifungal Agents" by people in Profiles.
-
Practical Update on Treatment of Oral Candidiasis. J Drugs Dermatol. 2024 Dec 01; 23(12):e186-e190.
-
Effect of the staging of rhino-orbital-cerebral mucormycosis on its management and clinical outcome. Indian J Ophthalmol. 2024 Oct 01; 72(10):1519-1523.
-
Targeted orbital intervention in the management of sino-orbital mucormycosis cases. Indian J Ophthalmol. 2024 Oct 01; 72(10):1488-1494.
-
Good Outcomes in Salvage Therapy of Fusariosis in Patients With Leukemia: Is It the Host or the Drug? Clin Infect Dis. 2024 Aug 16; 79(2):571-572.
-
Recurrent Pleural Effusion Associated With Candida Albicans Infection in Transplanted Kidney: A Case Report. Transplant Proc. 2024 Jul-Aug; 56(6):1509-1512.
-
The modern face of esophageal candidiasis in an oncology center: Correlating clinical manifestations, endoscopic grade, and pathological data in 323 contemporary cancer patients. J Infect. 2024 Jul; 89(1):106172.
-
Overview of Mycotic Keratitis. Cornea. 2024 Sep 01; 43(9):1065-1071.
-
Translational genetics identifies a phosphorylation switch in CARD9 required for innate inflammatory responses. Cell Rep. 2024 Mar 26; 43(3):113944.
-
A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus. mBio. 2024 Apr 10; 15(4):e0341323.
-
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer. 2024 Jun 01; 130(11):1964-1971.